AMTI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMTI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Applied Molecular Transport's other long-term assets for the quarter that ended in Sep. 2023 was $0.00 Mil.
Applied Molecular Transport's quarterly other long-term assets declined from Mar. 2023 ($1.41 Mil) to Jun. 2023 ($0.13 Mil) but then stayed the same from Jun. 2023 ($0.13 Mil) to Sep. 2023 ($0.00 Mil).
Applied Molecular Transport's annual other long-term assets increased from Dec. 2020 ($0.23 Mil) to Dec. 2021 ($1.15 Mil) and increased from Dec. 2021 ($1.15 Mil) to Dec. 2022 ($1.44 Mil).
The historical data trend for Applied Molecular Transport's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied Molecular Transport Annual Data | |||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | ||||||
Other Long Term Assets | 0.16 | 0.74 | 0.23 | 1.15 | 1.44 |
Applied Molecular Transport Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Other Long Term Assets | Get a 7-Day Free Trial | 1.47 | 1.44 | 1.41 | 0.13 | - |
GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
Shawn Cross | officer: Chief Financial Officer | 1825 K STREET SUITE 510, WASHINGTON DC 20006 |
Mahmood Tahir Ph.d. | director, officer: Chief Executive Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Brandon Hants | officer: VP, Finance & Bus. Ops. | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Douglas A. Rich | officer: Chief Technical Officer | C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362 |
Bittoo Kanwar | officer: Chief Medical Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Mrsny Randall Ph.d. | director, officer: Chief Scientific Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Aaron Vandevender | director | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
David Lamond | director | C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080 |
Epiq Capital Group, Llc | other: Managing member of 10% owner | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Chad Boeding | other: CEO of Managing Member | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Charlene A. Banard | director | C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080 |
John W Smither | director | C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301 |
Epq Llc Amt Ps | other: Owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Amtc Ps | other: Owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Amtb Ps | 10 percent owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
From GuruFocus
By GlobeNewswire GlobeNewswire • 12-22-2022
By PurpleRose PurpleRose • 08-04-2022
By Value_Insider Value_Insider • 11-10-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By PRNewswire • 10-04-2023
By PurpleRose PurpleRose • 08-10-2022
By Business Wire Business Wire • 07-11-2022
By sperokesalga sperokesalga • 03-03-2023
By PurpleRose PurpleRose • 07-12-2022
By PRNewswire • 10-04-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.